On October 28th, Jin10 Data reported that HuaLuan Biological announced that its specific shareholder, Gao Tou Development Plan, would reduce the company's shares in a centralized Bidding transaction by no more than 6,315,400 shares, or no more than 5.36% of the company's latest total share capital.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hua Lai Biology: Shareholders holding more than 5% of the shares plan to reduce their holdings by no more than 5.36%
On October 28th, Jin10 Data reported that HuaLuan Biological announced that its specific shareholder, Gao Tou Development Plan, would reduce the company's shares in a centralized Bidding transaction by no more than 6,315,400 shares, or no more than 5.36% of the company's latest total share capital.